Regulation of epithelial branching morphogenesis and cancer cell growth of the prostate by Wnt signaling

PLoS ONE

Volumn 3, Issue 5, 2008, Pages

  Wang, Bu Er ^a   Wang, Xi De ^a,b   Ernst, James A ^a   Polakis, Paul ^a   Gao, Wei Qiang ^a  

^a GENENTECH INC   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; AXIN2; BETA CATENIN; BETA GALACTOSIDASE; DICKKOPF 1; PROTEIN INHIBITOR; PROTEIN P63; T CELL FACTOR PROTEIN; WNT PROTEIN; ANDROGEN;

ANDROGEN THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; CANCER GROWTH; CARCINOGENESIS; CASTRATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NONHUMAN; ORGANOGENESIS; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; CELL MOTION; CYTOLOGY; EPITHELIUM CELL; METABOLISM; MORPHOGENESIS; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

MUS MUSCULUS; RATTUS;

ANDROGENS; CASTRATION; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL CELLS; HUMANS; MALE; MORPHOGENESIS; PROSTATE; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 48249127604     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002186     Document Type: Article

References (45)

1. Nusse R (2005) Wnt signaling in disease and in development. Cell Res 15: 28-32.
2. Nichrs C (2006) Function and biological rules of the Dickkopf family of Wnt modulators. Oncogene 25: 7469-7481.
3. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, et al. (2002) Wnt/ beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22: 1172-1183.
4. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, et al. (2002) Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 22: 1184-1193.
5. Polakis P (2000) Wnt signaling and cancer. Genes Dev 14: 1837-1851.
6. Ilyas M (2005) Wnt signalling and the mechanistic basis of tumour development. J Pathol 205: 130-144.
7. Shoemaker AR, Moser AR, Midgley CA, Clipson L, Newton MA, et al. (1998) A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice. Proc Natl Acad Sci U S A 95: 10826-10831.
8. Chen G, Shukeir N, Potti A, Sircar K, Aprikian A, et al. (2004) Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer 101: 1345-1356.
9. Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, et al. (2003) WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 201: 204-212.
10. Bruxvoort K, Charbonneau H, Giambernardi T, Goolsby J, Qian C, et al. (2007) Inactivation of Apc in the mouse prostate causes prostate carcinoma. Cancer Res 67: 2490-2496.
11. Verras M, Brown J, Li X, Nusse R, Sun Z (2004) Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells. Cancer Res 64: 8860-8866.
12. Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA (2001) Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/ Arrow. Nat Cell Biol 3: 683-686.
13. Semenov MV, Tamai K, Brott BK, Kuhl M, Sokol S, et al. (2001) Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11: 951-961.
14. Mao B, Wu W, Li Y, Hoppe D, Stannek P, et al. (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411: 321-325.
15. Sugimura Y, Cunha GR, Donjacour AA (1986) Morphogenesis of ductal networks in the mouse prostate. Biol Reprod 34: 961-971.
16. Timms BG, Mohs TJ, Didio LJ (1994) Ductal budding and branching patterns in the developing prostate. J Urol 151: 1427-1432.
17. Lipschutz JH, Foster BA, Cunha GR (1997) Differentiation of rat neonatal ventral prostates grown in a serum-free organ culture system. Prostate 32: 35-42.
18. Wang BE, Shou J, Ross S, Koeppen H, De Sauvage FJ, et al. (2003) Inhibition of epithelial ductal branching in the prostate by sonic hedgehog is indirectly mediated by stromal cells. J Biol Chem 278: 18506-18513.
19. Hayward SW, Baskin LS, Haughney PC, Cunha AR, Foster BA, et al. (1996) Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle. Acta Anat (Basel) 155: 81-93.
20. Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, et al. (2000) p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 157: 1769-1775.
21. Robinson EJ, Neal DE, Collins AT (1998) Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 37: 149-160.
22. Coffey DS, Shimazaki J, Williams-Ashman HG (1968) Polymerization of deoxyribonucleotides in relation to androgen-induced prostatic growth. Arch Biochem Biophys 124: 184-198.
23. Furuya Y, Isaacs JT (1993) Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation. Endocrinology 133: 2660-2666.
24. Wright AS, Douglas RC, Thomas LN, Lazier CB, Rittmaster RS (1999) Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase. Endocrinology 140: 4509-4515.
25. Maretto S, Cordenonsi M, Dupont S, Braghetta P, Broccoli V, et al. (2003) Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci (USA) 100: 3299-3304.
26. Corey E, Quinn JE, Buhler KR, Nelson PS, Macoska JA, et al. (2003) LuCaP 35: a new model of prostate cancer progression to androgen independence. Prostate 55: 239-246.
27. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, et al. (1995) Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell & Devel Biol Anim 31: 14-24.
28. Lipschutz JH, Samid D, Cunha GR (1996) Phenylacetate is an inhibitor of prostatic growth and development in organ culture. J Urol 155: 1762-1770.
29. Thomson AA, Cunha GR (1999) Prostatic growth and development are regulated by FGF10. Development 126: 3693-3701.
30. Wang XD, Leow CC, Zha J, Tang Z, Modrusan Z, et al. (2006) Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Dev Biol 290: 66-80.
31. Maddison LA, Huss WJ, Barrios RM, Greenberg NM (2004) Differential expression of cell cycle regulatory molecules and evidence for a "cyclin switch" during progression of prostate cancer. Prostate 58: 335-344.
32. Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, et al. (2004) A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A 101: 17204-17209.
33. van Es JH, Jay P, Gregorieff A, van Gijn ME, Jonkheer S, et al. (2005) Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol 7: 381-386.
34. Li Y, Rosen JM (2005) Stem/progenitor cells in mouse mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 10: 17-24.
35. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, et al. (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448-452.
36. Shidaifat F, Daradka M, Al-Omari R (2004) Effect of androgen ablation on prostatic cell differentiation in dogs. Endocr Res 30: 327-334.
37. Xin L, Lawson DA, Witte ON (2005) The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci U S A 102: 6942-6947.
38. Verras M, Sun Z (2006) Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett 237: 22-32.
39. Polakis P (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 17: 45-51.
40. Zhu H, Mazor M, Kawano Y, Walker MM, Leung HY, et al. (2004) Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor. Cancer Res 64: 7918-7926.
41. Katoh M (2001) Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer. Int J Oncol 19: 1003-1007.
42. Zi X, Guo Y, Simoneau AR, Hope C, Xie J, et al. (2005) Expression of Frzb/ secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res 65: 9762-9770.
43. Kawano Y, Kitaoka M, Hamada Y, Walker MM, Waxman J, et al. (2006) Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene 25: 6528-6537.
44. Shou J, Ross S, Koeppen H, de Sauvage FJ, Gao WQ (2001) Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res 61: 7291-7297.
45. Shou J, Soriano R, Hayward SW, Cunha GR, Williams PM, et al. (2002) Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression. Proc Natl Acad Sci U S A 99: 2830-2835.